Corrigendum to “Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response” [Eur J Med Chem. 192 2020 112158] (European Journal of Medicinal Chemistry (2020) 192, (S0223523420301252), (10.1016/j.ejmech.2020.112158))

Wei Cheng Wu, Yi Min Liu, Mei Hsiang Lin, Yu Hsuan Liao, Mei Jung Lai, Hsun Yueh Chuang, To Yu Hung, Chun Han Chen, Jing Ping Liou

研究成果: 雜誌貢獻評論/辯論同行評審

摘要

The authors regret that the affiliation of the second corresponding author (C.-H. Chen) in the footnote of pdf version of this article was misplaced. The correct version should be: The authors would like to apologise for any inconvenience caused.
原文英語
文章編號112329
期刊European Journal of Medicinal Chemistry
196
DOIs
出版狀態已發佈 - 六月 15 2020

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Organic Chemistry

指紋 深入研究「Corrigendum to “Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response” [Eur J Med Chem. 192 2020 112158] (European Journal of Medicinal Chemistry (2020) 192, (S0223523420301252), (10.1016/j.ejmech.2020.112158))」主題。共同形成了獨特的指紋。

引用此